Femoden

Фемоден Drug photo

The description is actual on 24.11.2014

  • Latin name: Femoden
  • ATH code: G03AA10
  • Active ingredient: Ethinylestradiol (Ethinylestradiol), Gestoden (Gestodene)
  • Producer: Schering AG (Germany)

Structure

This medicine contains in the structure ethinylestradiol and gestoden.

Besides, in it there are following additional substances: lactoses monohydrate, povidone 25000, calcium carbonate, calcium sodium edetat, magnesium stearate, starch, povidone 700000, PEG-6000, wax montanglikolevy, talc.

Release form

Dragee in blisters.

Pharmacological action

Drug renders contraceptive and estrogen-gestagennoye action.

Pharmacodynamics and pharmacokinetics

This medicine belongs to means with a low dosage of hormones. It influences the hypothalamus-hypophysis-ovaries system. Femoden suppresses synthesis of hormones which stimulate maturing of follicles. It provokes ovulation inhibition, and also activates changes in secretion of cervical slime.

Drug has no androgenic activity. It also reduces an endometria susceptibility to fixing of a blastocyste.

After oral administration gestoden and ethinylestradiol are quickly and completely absorbed. During primary passing through a liver gestoden it is not split, and ethinylestradiol, on the contrary, is substantially metabolized. At the same time the most part of the last contacts proteins of plasma. It also gets into breast milk.

Bioavailability of medicine makes 99%. Gestoden contacts globulin and albumine of plasma which connect sexual steroids. As well as ethinylestradiol, it is removed from an organism in the form of metabolites with urine and bile.

Indications to use

Drug is used as contraceptive means. Besides, it can be appointed for normalization of a menstrual cycle, and also if bleedings too strong, for their reduction.

Contraindications

Femoden it is impossible to apply at negative reactions of an organism to its components, liver tumors (including in the anamnesis), a heavy diabetes mellitus with complications on vascular system with a heavy gipertriglitseridemiya, migraines (with focal neurologic manifestations in the anamnesis), uterine bleedings of not established origin, heavy disturbances of functions of a liver, a thromboembolism (including in the anamnesis, and also at the increased risk of its development), pancreatitis with a heavy gipertriglitseridemiya (including in the anamnesis), pregnancies.

Side effects

Drug intake can cause:

  • emergence hloazm;
  • nausea;
  • change of weight;
  • small tortoiseshell;
  • liquid delay;
  • nagrubaniye of mammary glands;
  • rash;
  • allocations from nipples;
  • headache;
  • change of vulval secretion;
  • change of a libido;
  • Quincke's edema;
  • tachycardia;
  • change of mood;
  • painful feelings in a breast;
  • vomiting;
  • intolerance of contact lenses;
  • anaphylaxis;
  • migrenozny pains.

Application instruction of Femoden (Way and dosage)

The instruction on Femoden reports that it is necessary to accept a dragee orally. It is necessary to do it daily, approximately in at one time. Dragees are washed down with a water quantity. About one piece for three weeks is accepted. After that the seven-day break becomes and dragees are accepted again. Bleedings usually begin for the 2 or 3 day after a break and can end before it is necessary to pass to new packaging.

The application instruction of Femoden reports that if before the woman did not accept any hormonal contraceptives, it is necessary to take medicine from the first day of a menstrual cycle or for 2-5 day. At the same time the first week it is desirable to be protected from pregnancy in addition.

If before other combined peroral means were accepted, Femoden next day after reception of the last medicine, and not later than the next day after a usual week break on periods is recommended to accept by no means.

Transition from drugs which contain only gestagena or from the intrauterine drugs releasing gestagen can be carried out in any day. In case of an implant or intrauterine means – in day of removal; when using solution for internal introduction – from the next day. At the same time it is necessary to apply in addition barrier methods of protection within the first week.

If the woman did abortion in the I trimester of pregnancy, it is necessary to accept drug immediately. There is no need for additional protection. If abortion was made in the II trimester, and also after the delivery it is desirable to begin Femoden's reception in 3 or 4 weeks. If reception began later, other methods of protection in addition are necessary, besides, it is necessary to be convinced that there is no pregnancy.

In case of Femoden's admission less than for 12 hours, action of a contraceptive is still effective. Medicine needs to be taken as soon as possible. The following dosage is accepted in former time. And if reception is delayed more than for 12 hours (but not longer than for 7 days), the necessary dosage needs to be accepted at the first opportunity. Then dragees are accepted in usual time. For all week the additional method of protection against undesirable conception is applied. It is necessary to exclude probability of pregnancy also.

If administration of drug was missed more than for 12 hours on the 3rd week of a course, the dragee needs to be accepted as soon as possible. Further inclusion in usual time continues, and then the following packaging begins. Until it ends, bleeding of cancellation is improbable. At the same time there can be smearing allocations and some bleeding during drug intake. Besides, it is possible to take the put seven-day break when the first pack ends. Only after that to pass to following.

When there was an admission of administration of drug, and then during the usual seven-day period there was no bleeding, it is necessary to exclude undesirable pregnancy.

If the woman had cases of vomiting or diarrhea in 4 and less hours after taking the medicine, in addition barrier methods of protection are necessary. It is also necessary to be guided in that case by recommendations of the instruction at the admission of a dragee.

There are cases when the menstrual cycle needs to be delayed. Then drug continues to be accepted, without doing a seven-day break, so much, how many it will be required until the second packaging does not end. At the same time there can be smearing allocations or some insignificant bleeding. On end of the second pack a seven-day break needs to be taken surely.

Overdose

Overdose by this means can lead to vulval bleedings, tachycardia, nausea smearing vulval to allocations, vomiting.

There is no specific treatment. The decision on the scheme of therapy is made by the gynecologist.

Interaction

Some antibiotics can cause reduction of level of active ingredients of drug in a blood plasma. Besides, such means as Hydantoin, Phenylbutazone and Rifampicin can dull their effect.

Terms of sale

Is on sale according to the recipe of the gynecologist.

Storage conditions

It is necessary to keep this means only in original packaging. Temperature at the same time has to be not above 25 °C. It is impossible to apply after expiry date.

Period of validity

It is necessary to store medicine not longer than five years.

About Femodena

About Femodena at forums the most different meet. There are no unambiguously negative opinions. Nevertheless, many women complain of side effects. As a rule, report about a weight set, nausea, vomiting, changes in mood. However those to whom drug suited are satisfied.

Comments of doctors on Femodena report that means can really give side effects. It just does not suit some. Nevertheless, it is often recommended not only for protection from pregnancy. So, it can be appointed at an endometria inflammation against antiinflammatory therapy. Besides, Femoden before EKO in certain cases is accepted if before there was an EKO unsuccessful protocol.

Femoden's price where to buy

Femoden's price in drugstores makes usually about 580 rubles.

Zdravzona

  • Femoden No. 21 a tabletkishering Gmbh and To. Produktsions KG

Drugstore of IFC

  • Femoden drzh No. 21, Schering Aggermaniya
to show still

Apteka24

  • Femodenschering GmbH & Co. Productions (Germany)
Section: Hormonal Contraceptives
PAY ATTENTION! Information on drugs on the website is help generalizing, collected from public sources and can form the basis for making decision on use of medicines it is not aware of treatment. Before medicine use Femoden surely consult with the attending physician.